Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis
for
Dermatitis, Atopic, Eczema
Location: Boston MA
Sponsor: NeoStrata Company, Inc.
Sex: All
Age: 18+
Code: NCT02286700
Phase 3, Recruiting
An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
for
Metastatic Breast Cancer
Location: Boston MA
Sponsor: Rogers Sciences Inc.
Sex: All
Age: 18+
Code: NCT02939274
Phase 2, Recruiting
Chemical Peels and Fractional Laser on IGF-1 Levels in Skin
for
Skin Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 55+
Code: NCT03775031
Recruiting
Home OCT Fluid Visualization Agreement Study
for
Neovascular Age-related Macular Degeneration
Location: Boston MA, Glen Burnie MD, Norfolk VA, Richmond VA,
Sponsor: Notal Vision Inc.
Sex: All
Age: 55+
Code: NCT04907409
Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
for
Agitation Associated With Alzheimer's Dementia
Location: Boston MA, Toms River NJ, Maitland FL, Orlando FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 55+
Code: NCT06651567
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers
for
Foot Ulcer, Diabetes
Location: Boston MA, New Haven CT, Souderton PA, York PA,
Sponsor: KeraCure
Sex: All
Age: 18+
Code: NCT00330265
Phase 2, Recruiting
Parkinson's Disease in Asian Americans
for
Parkinson's Disease
Location: Boston MA
Sponsor: Tufts University
Sex: All
Age: 18+
Code: NCT05532982
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
for
Sjögren's Syndrome
Location: Boston MA, Voorhees Township NJ, Trois-Rivieres,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06747949
Phase 3, Recruiting
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
for
ALS
Location: Boston MA, Philadelphia PA, Montreal,
Sponsor: Amylyx Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT06665165
Phase 1, Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Boston MA, Hartford CT, New Haven CT, Bridgeport CT,
Sponsor: Cytokinetics
Sex: All
Age: 18 - 70+
Code: NCT06736574
Phase 3, Recruiting
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Location: Boston MA, Bristol CT, Middletown NY, Harris NY,
Sponsor: Nuo Therapeutics
Sex: All
Age: 18+
Code: NCT02352467
Recruiting
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
for
Gram-negative Bacterial Infection
Location: Boston MA, Durham NC, Indianapolis IN, Louisville KY,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT06462235
Phase 2, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Boston MA, Lebanon NH, Stony Brook NY, Livingston NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase 2, Recruiting
Palbociclib and Pembrolizumab In Central Nervous System Metastases
for
Metastatic Malignant Neoplasm to Brain,
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT02896335
Phase 2, Recruiting
NEO100 and High-Grade Meningioma
for
Residual, Progressive or Recurrent Grade II or III Meningioma
Location: Boston MA, Dallas TX, Los Angeles CA, Santa Monica CA,
Sponsor: Neonc Technologies, Inc.
Sex: All
Age: 12+
Code: NCT05023018
Phase 2, Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis